Vimarsana
Biggest News Aggregation in the World

Christopherj Schaber News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Christopherj Schaber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Christopherj Schaber Today - Breaking & Trending Today

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split - Soligenix (NASDAQ:SNGX) - Vimarsana News

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split - Soligenix (NASDAQ:SNGX)

Most shareholders can vote by calling 1-833-782-7145 PRINCETON, N.J., May 23, 2024 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing

Soligenix Encourages Stockholders to Vote Prior to Annual Meeting - Vimarsana News

Soligenix Encourages Stockholders to Vote Prior to Annual Meeting

Annual Meeting to be held May 23, 2024 PRINCETON, N.J., May 20, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to...

Soligenix Announces Formation of Behçet's Disease Medical Advisory Board - Vimarsana News

Soligenix Announces Formation of Behçet's Disease Medical Advisory Board

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, ... - Vimarsana News

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, ...

Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, ...

FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease - Vimarsana News

FDA Grants Soligenix "Fast Track" Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease

PRINCETON, N.J., Jan. 8, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...